Samsung Biologics, Foreign Investors Net Sell 4,808 Shares... Stock Price Down 0.87%

Samsung Biologics has ranked among the top searched stocks on 4 days within the past month.

As of 7:40 PM on the 19th, Samsung Biologics is trading at 809,000 KRW, up 0.87% from the previous day. This marks a 10.37% increase compared to July 31. Samsung Biologics is known as the holding company for Samsung Group's bio business.

Today, foreign investors have net sold 4,808 shares of Samsung Biologics, while institutions have net bought 6,934 shares, according to provisional data. Over the past 5 days, individual investors have net sold 152,149 shares, whereas foreign investors and institutions have net bought 114,925 shares and 45,187 shares, respectively.

On August 12, Samsung Biologics was a market highlight for its "strong performance following the announcement of investment in Songdo Plant 4."

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.